WellAir Investment

June 2020, Super Capital Group is excited to support WellAir Group Ltd., the world leader in medical and commercial grade air disinfection products. WellAir’s Novaerus products are proven to deactivate 99.99% of the Sars-Cov-2 surrogate MS2 in the air in the room. Novaerus products are used by more than 1,000 healthcare facilities worldwide. www.wellairsolutions.com www.novaerus.com